Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Intestinal Neoplasms

pyrroles has been researched along with Intestinal Neoplasms in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (14.29)29.6817
2010's18 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bebawi, E; Hatem, R; Schampaert, E1
Avniel-Polak, S; Gross, DJ; Grozinsky-Glasberg, S; Uri, I1
Khagi, S; Saif, MW1
Akahoshi, S; Inoue, K; Kiyota, Y; Kiyozumi, Y; Motooka, Y; Yamaguchi, R; Yoshida, Y1
Hosaka, S; Kawamoto, S; Kikutake, T; Nagao, S; Umemoto, S; Yonemitsu, K; Yoshida, T1
Grandhi, MS; Lafaro, KJ; Pawlik, TM1
Kunz, PL; Phan, AT; Reidy-Lagunes, DL1
Allen, E; Hanahan, D; Li, L; Miéville, P; Peng, MW; Saghafinia, S; Warren, CM1
Chae, H; Chang, HM; Cho, H; Hong, SM; Hong, YS; Kang, YK; Kim, KP; Kim, SC; Kim, TW; Ryoo, BY; Ryu, MH; Song, MJ; Yoo, C1
Azouz, MM; Bouassida, M; Chelbi, E; El Bouchtili, S; Ezzine, H; Hamzaoui, L; Mahmoudi, M; Medhioub, M; Touinsi, H1
Chen, J; Chen, M; Feng, ST; Huang, K; Li, ZP; Lin, Y; Luo, Y; Xu, L1
Hartmann, JT; Kanz, L1
Bukowski, R; Flodgren, P; Ravaud, A; Schöffski, P1
Akyurek, N; Benekli, M; Buyukberber, S; Coskun, U; Demirci, U; Karakan, T; Tonyali, O; Yildiz, R1
Briaire-de Bruijn, IH; Gelderblom, H; Hogendoorn, PC; Jordanova, ES; Ottenhoff, TH; Savage, ND; van der Burg, SH; van Dongen, M; van Hall, T; Walburg, KV1
Benekli, M; Bilge Yilmaz, I; Buyukberber, S; Coskun, U; Demirci, U; Erdem, O; Ozturk, B1
Choi, CI; Janakiram, NB; Li, Q; Mohammed, A; Rao, CV; Steele, VE; Zhang, Y1
Ashley, SW; Grover, S; Raut, CP1
Hazama, S; Inoue, Y; Oka, M; Suzuki, N; Yoshino, S1
Campos, TL; Choi, J; Han, G; Kvols, LK; Schell, MJ; Strosberg, JR; Valone, TL; Weber, JM1
Kidd, M; Malfertheiner, MV; Modlin, IM; Pfragner, R; Schally, AV1

Reviews

3 review(s) available for pyrroles and Intestinal Neoplasms

ArticleYear
Update in the Therapy of Advanced Neuroendocrine Tumors.
    Current treatment options in oncology, 2017, 11-16, Volume: 18, Issue:12

    Topics: Combined Modality Therapy; Cytoreduction Surgical Procedures; Everolimus; Humans; Indoles; Intestinal Neoplasms; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Somatostatin; Stomach Neoplasms; Sunitinib

2017
Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.
    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2015, Volume: 19, Issue:12

    Topics: Antineoplastic Agents; Humans; Indoles; Intestinal Neoplasms; Liver Neoplasms; Liver Transplantation; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Pyrroles; Stomach Neoplasms; Sunitinib

2015
Small intestine gastrointestinal stromal tumors.
    Current opinion in gastroenterology, 2012, Volume: 28, Issue:2

    Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Neoadjuvant Therapy; Neoplasm Metastasis; Piperazines; Prognosis; Pyrimidines; Pyrroles; Sunitinib

2012

Trials

1 trial(s) available for pyrroles and Intestinal Neoplasms

ArticleYear
A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:9

    Topics: Acrylic Resins; Adult; Aged; Angiogenesis Inhibitors; Disease-Free Survival; Embolization, Therapeutic; Female; Gelatin; Hepatic Artery; Humans; Indoles; Intestinal Neoplasms; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neuroendocrine Tumors; Proportional Hazards Models; Pyrroles; Statistics, Nonparametric; Sunitinib; Treatment Outcome; Tumor Burden; Vascular Endothelial Growth Factor A

2012

Other Studies

17 other study(ies) available for pyrroles and Intestinal Neoplasms

ArticleYear
Potential Sunitinib-Induced Coronary Artery and Aortic Dissections.
    The Canadian journal of cardiology, 2017, Volume: 33, Issue:6

    Topics: Antineoplastic Agents; Aortic Aneurysm, Thoracic; Aortic Dissection; Computed Tomography Angiography; Coronary Aneurysm; Coronary Angiography; Female; Humans; Indoles; Intestinal Neoplasms; Middle Aged; Pyrroles; Sunitinib

2017
Neuroendocrine tumors: treatment updates.
    JOP : Journal of the pancreas, 2013, Jul-10, Volume: 14, Issue:4

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Everolimus; Humans; Indoles; Intestinal Neoplasms; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Pyrroles; Sirolimus; Stomach Neoplasms; Sunitinib; Treatment Outcome

2013
[A case of imatinib-resistant gastrointestinal stromal tumor treated with low-dose sunitinib].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2013, Volume: 40, Issue:13

    Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Recurrence; Salvage Therapy; Sunitinib

2013
[A case of small intestinal gastrointestinal stromal tumor (GIST) with peritoneal dissemination, treated effectively with molecular target drug after operation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2014, Volume: 41, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Molecular Targeted Therapy; Peritoneal Neoplasms; Piperazines; Pyrimidines; Pyrroles; Sunitinib

2014
New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Clinical advances in hematology & oncology : H&O, 2015, Volume: 13, Issue:5 Suppl 5

    Topics: Antineoplastic Agents; Everolimus; Hormones; Humans; Indoles; Intestinal Neoplasms; Intestines; Molecular Targeted Therapy; Neuroendocrine Tumors; Octreotide; Pancreas; Pancreatic Neoplasms; Pyrroles; Somatostatin; Stomach; Stomach Neoplasms; Sunitinib

2015
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
    Cell reports, 2016, 05-10, Volume: 15, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Glycolysis; Humans; Imidazoles; Indazoles; Indoles; Intestinal Neoplasms; Lactic Acid; Membrane Transport Proteins; Mice; Models, Biological; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Signal Transduction; Sirolimus; Stomach Neoplasms; Sunitinib; TOR Serine-Threonine Kinases; Up-Regulation

2016
Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor.
    Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Everolimus; Female; Humans; Indoles; Intestinal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib

2017
Gastrointestinal stromal tumours (GISTs): A descriptive study on 29 cases.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2016, Volume: 17, Issue:4

    Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Intestine, Small; Male; Middle Aged; Proto-Oncogene Proteins c-kit; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib; Survival Rate; Tumor Burden; Weight Loss

2016
Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
    BMC cancer, 2017, 02-23, Volume: 17, Issue:1

    Topics: Adult; Antineoplastic Agents; Female; Humans; Indoles; Intestinal Neoplasms; Kaplan-Meier Estimate; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrroles; Retrospective Studies; Stomach Neoplasms; Sunitinib; Tomography, X-Ray Computed; Treatment Outcome

2017
Sunitinib and periodic hair depigmentation due to temporary c-KIT inhibition.
    Archives of dermatology, 2008, Volume: 144, Issue:11

    Topics: Chemotherapy, Adjuvant; Follow-Up Studies; Hair Color; Humans; Hypopigmentation; Ileum; Indoles; Intestinal Neoplasms; Leiomyoma; Male; Middle Aged; Neoplasm Recurrence, Local; Periodicity; Proto-Oncogene Proteins c-kit; Pyrroles; Risk Assessment; Sunitinib; Twins, Monozygotic

2008
Tyrosine kinase inhibition in renal cell carcinoma and gastrointestinal stromal tumours: case reports.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20 Suppl 1

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Female; Gastrointestinal Stromal Tumors; Humans; Indoles; Intestinal Neoplasms; Intestine, Small; Kidney Neoplasms; Male; Middle Aged; Protein-Tyrosine Kinases; Pyrroles; Sunitinib

2009
Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Acute Disease; Anti-Inflammatory Agents; Antineoplastic Agents; Benzamides; Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Liver; Liver Failure; Middle Aged; Peritoneal Neoplasms; Piperazines; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sunitinib

2010
Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors.
    International journal of cancer, 2010, Aug-15, Volume: 127, Issue:4

    Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Benzamides; Female; Forkhead Transcription Factors; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunoenzyme Techniques; Indoles; Interleukin-10; Intestinal Neoplasms; Macrophages; Male; Piperazines; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptors, Cell Surface; Sunitinib; T-Lymphocytes, Regulatory

2010
Acne rosacea associated imatinib mesylate in a gastrointestinal stromal tumor patient.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:3

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Biopsy; Gastrointestinal Stromal Tumors; Histamine Antagonists; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Keratoderma, Palmoplantar; Liver Neoplasms; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Rosacea; Skin; Skin Pigmentation; Sunitinib; Treatment Outcome

2011
Chemoprevention of colon and small intestinal tumorigenesis in APC(Min/+) mice by licofelone, a novel dual 5-LOX/COX inhibitor: potential implications for human colon cancer prevention.
    Cancer prevention research (Philadelphia, Pa.), 2011, Volume: 4, Issue:12

    Topics: Adenomatous Polyposis Coli Protein; Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Blotting, Western; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Female; Humans; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Pyrroles; Real-Time Polymerase Chain Reaction; RNA, Messenger

2011
[A case of gastrointestinal stromal tumor (GIST) successfully treated with resection after a long-term control medication by molecular targeted drugs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2011, Volume: 38, Issue:12

    Topics: Antineoplastic Agents; Benzamides; Combined Modality Therapy; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Intestinal Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Piperazines; Pyrimidines; Pyrroles; Sunitinib; Tomography, X-Ray Computed

2011
Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors.
    Cancer, 2008, Mar-15, Volume: 112, Issue:6

    Topics: Apoptosis; Bronchial Neoplasms; Carcinoid Tumor; Caspase 3; Cell Cycle; Cell Proliferation; Cytotoxins; Doxorubicin; Flow Cytometry; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Humans; Intestinal Neoplasms; Intestine, Small; Ki-67 Antigen; Lung Neoplasms; Pyrroles; Receptors, LHRH; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured

2008